# Dexmedetomidine on Prevention of Side Effects of Hemabate

> **NCT02220361** · PHASE4 · UNKNOWN · sponsor: **Jin Ni** · enrollment: 120 (actual)

## Conditions studied

- Gynecological Patient

## Interventions

- **DRUG:** placebo
- **DRUG:** low dose dexmedetomidine
- **DRUG:** high dose dexmedetomidine

## Key facts

- **NCT ID:** NCT02220361
- **Lead sponsor:** Jin Ni
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02220361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02220361, "Dexmedetomidine on Prevention of Side Effects of Hemabate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02220361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*